INTENSITY-MODULATED PROTON THERAPY MARKET ANALYSIS (2020-2027)

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
INTENSITY-MODULATED PROTON THERAPY MARKET
ANALYSIS (2020-2070)

• Intensity-Modulated Proton Therapy Market-
• Global Industry Insights, Trends, Outlook, and
  Opportunity Analysis 2020-2027

3

• Intensity modulated proton therapy is a proton
  therapy (an external beam therapy) that uses
  ionization radiation. In intensity modulated
  proton therapy, a beam of protons target tumors
  with the help of proton accelerators. These
  charged particles damage the DNA cells and stop
  them from dividing, thus slowing the tumor
  growth. Intensity modulated proton therapy
  treatment is carefully planned by using computed
  tomography (CT) and magnetic resonance (MRI)
  images of patients associated with computerized
  dose calculation to define the dose tolerability
  suitable to the tumor shape. The equipment used
  in intensity modulated proton therapy is mainly
  medical linear accelerators. The treatment time
  is around 15 minutes to 1 hour.

4

• Global Intensity-Modulated Proton
• Therapy Market- Drivers
• The rising prevalence of non-communicable
  diseases such as cancer is a major burden
  globally. According to the World Health
  Organization, cancer accounted for around 9.6
  million deaths across the globe in 2018.
  Moreover, healthcare facilities are focusing on
  adoption of intensity modulated proton therapy
  due to its safety and efficiency in treatment of
  cancer. In February 2020, IBA Ion Bean
  Application announced that they have signed a
  contract to install Proteus ONE, a compact proton
  therapy at RSPAD Gatot Soebroto Presidential
  Hospital in Jakarta, Indonesia.

5

• Global Intensity-Modulated Proton Therapy Market-
  Impact of COVID-19
• The COVID-19 pandemic has impacted growth of
  various markets, and it is also expected to
  hamper the growth of the global intensity
  modulated proton therapy market during 2020. The
  pandemic has directly affected demand for the
  intensity modulated proton therapy as cancer
  patients are at higher risk of getting infected
  by COVID-19. Moreover, implementation of
  nationwide lockdown in several countries and
  safety precautions suggested by World Health
  Organization to decrease the risk of spread of
  COVID-19 while performing treatments and therapy
  procedures has made it difficult to administer
  therapy in cancer patients. As a result, the
  COVID-19 pandemic is expected to hamper growth of
  the global intensity modulated proton therapy
  market.

6

• Global Intensity-Modulated Proton Therapy Market-
  Restraints
• Intensity modulated proton therapy devices are
  large in size and also occupy larger space. The
  investment is high due to additional setup cost
  of the equipment which increases the investment
  cost and thereby limits the market growth.
  Moreover, high cost proton therapy is expected to
  affect the growth of the market. For instance,
  according to The Institute of Clinical and
  Economic Review, the cost of intensity modulated
  proton therapy for cancer patients in the U.S is
  US 73,000. These factors are expected to
  restrain the growth of the global intensity
  modulated proton therapy market.

7

• Global Intensity-Modulated Proton Therapy Market-
  Regional Analysis
• On the basis of region, the global intensity
  modulated proton therapy market is segmented into
  North America, Latin America, Europe, Asia
  Pacific, Middle East, and Africa. The burden of
  cancer is growing across North America, and
  various organizations such as Pan America Health
  Organization (PAHO) are operating in North
  America to reduce cancer mortality. Major players
  in the market are focused on research and
  development which is expected to drive global
  intensity modulated proton therapy market growth
  during forecast period. For instance, in 2018,
  Varian Medical System, a radiation oncology
  treatments and software maker, introduced a
  single room intensity modulated proton therapy
  system called 'ProBeam 360' at the 2018 American
  Society of Radiation Oncology meeting.

8

• Moreover, in Europe, cancer is the highest cause
  of death and morbidity. For instance, According
  to the European Journal of Cancer, in 2018,
  Cancer accounted for 1.9 million deaths in
  Europe. Therefore, the increasing disease
  prevalence in the region is expected to create
  growth opportunities for players to introduce
  oncology treatments and expand their presence.
  Market players are focusing on strategies such as
  acquisitions and mergers in order to strengthen
  their market share in global intensity modulated
  proton therapy market. For instance, in January
  2020, Ion Beam Application S.A, a leading
  provider of proton therapy solutions, announced
  that the company has signed a contract with
  International Charity Foundation Cartu, the
  largest charity organization in Georgia. The
  contract includes clinical use of Proteus ONE
  solution for scientific research in campus of
  Kutaisi International University, in Georgia.

9

• Furthermore, the increasing number of healthcare
  facilities offering intensity modulated proton
  therapy in Asia Pacific is expected to favor
  growth of the global intensity modulated proton
  therapy market in the region. For instance, in
  2019, Apollo Hospitals Enterprise Limited, an
  Indian hospital chain, started the Apollo Proton
  Cancer Centre (APCC) in India equipped with
  intensity modulated proton therapy and image
  guided radiotherapy.

10

• Global Intensity-Modulated Proton Therapy Market
  - Competitive Analysis.
• Key players operating in the global intensity
  modulated proton therapy market are Ion Beam
  Applications SA, Hitachi Ltd, Varian Medical
  Systems, Mevion Medical Systems, Inc., Mitsubishi
  Electric Corporation, ProNova Solutions, Proton
  International, Sumitomo Heavy Industries, Ltd,
  and Apollo Hospitals Enterprise Limited.
• Key Developments-
• In 2019, Ion Beam Application S.A, a leading
  provider of proton therapy solutions, announced
  an agreement with University of Kansas Health
  System, under this agreement, Ion Beam
  Application S.A will establish proton therapy
  centre with intensity modulated proton therapy at
  the main campus of University in Kansas.
• In 2018, the Miami Cancer Institute part of
  Baptist Health South Florida announced that they
  have started South Floridas First proton therapy
  centre with intensity modulated proton therapy.

11

• Global Intensity - Modulated Proton Therapy
  Market - Taxonomy

• By Treatment Type-
• Single Room
• Multiple Room
• By Indication-
• Brain Cancer
• Pediatric Cancer
• Lung Cancer
• Prostate Cancer
• Gastro-intestinal Cancer
• Head and Neck Cancer
• Others

• By Region-North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

12

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Buy Now
• Reference https//www.coherentmarketinsights.com/
  ongoing-insight/intensity-modulated-proton-therapy
  -market-4106

13
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

14
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

15

• Thank You!
• Kindly follow CMI Social Media
  Profiles for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/